IRIS UniCatt

Siciliano, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.082
EU - Europa 2.478
AS - Asia 2.192
SA - Sud America 377
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 38
OC - Oceania 4
Totale 8.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.012
SG - Singapore 1.110
DE - Germania 1.003
CN - Cina 501
SE - Svezia 416
BR - Brasile 319
IT - Italia 224
UA - Ucraina 208
FR - Francia 173
VN - Vietnam 166
GB - Regno Unito 115
IE - Irlanda 103
FI - Finlandia 80
IN - India 65
ID - Indonesia 64
TR - Turchia 50
RU - Federazione Russa 42
BD - Bangladesh 41
JP - Giappone 41
CA - Canada 40
HK - Hong Kong 37
IQ - Iraq 24
AR - Argentina 23
BE - Belgio 23
IR - Iran 21
PL - Polonia 20
MX - Messico 18
NL - Olanda 15
CI - Costa d'Avorio 13
AE - Emirati Arabi Uniti 9
AT - Austria 9
EC - Ecuador 9
PK - Pakistan 9
SA - Arabia Saudita 9
EU - Europa 8
LT - Lituania 8
VE - Venezuela 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
MA - Marocco 6
UZ - Uzbekistan 6
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
DK - Danimarca 4
PE - Perù 4
BO - Bolivia 3
BY - Bielorussia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
KG - Kirghizistan 3
MY - Malesia 3
PT - Portogallo 3
BH - Bahrain 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AD - Andorra 1
AL - Albania 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.180
Salva come PNG Salva come JPEG
Città #
Singapore 674
Chandler 470
Ashburn 289
San Jose 236
Jacksonville 121
Beijing 111
San Mateo 104
Dublin 102
Dallas 87
New York 82
Ann Arbor 74
The Dalles 66
Nürnberg 62
Jakarta 59
Ho Chi Minh City 58
Wilmington 58
Cattolica 57
Nanjing 57
Los Angeles 54
Lauterbourg 50
Boston 49
Munich 47
Dearborn 46
Hanoi 46
Tokyo 39
Woodbridge 39
Izmir 38
Frankfurt am Main 35
Helsinki 32
Marseille 32
Princeton 32
Redwood City 31
Hong Kong 29
Rome 29
Nanchang 27
Bremen 26
Houston 26
Moscow 26
Zhengzhou 25
Brussels 23
Lawrence 23
Santa Clara 23
São Paulo 23
Tianjin 21
Augusta 20
Buffalo 20
Hangzhou 20
Hefei 20
Lancaster 20
Leawood 19
Andover 18
Hebei 17
Seattle 16
Warsaw 16
Boardman 15
Phoenix 15
Shenyang 15
Milan 14
Shanghai 14
Abidjan 13
Atlanta 13
Changsha 13
Fairfield 13
Orem 13
Falls Church 12
Paris 12
Turku 12
Chicago 11
Kunming 11
London 11
Stockholm 11
Amsterdam 10
Las Vegas 10
Norwalk 10
Toronto 10
University Park 10
Brooklyn 9
Guangzhou 9
Salvador 9
Baghdad 8
Curitiba 8
Kish 8
Nuremberg 8
Rio de Janeiro 8
Bologna 7
Da Nang 7
Jiaxing 7
Mountain View 7
Chennai 6
Detroit 6
Dhaka 6
Goiânia 6
Haiphong 6
Jinan 6
Kent 6
Mcallen 6
Memphis 6
Montreal 6
Riyadh 6
Tashkent 6
Totale 4.259
Salva come PNG Salva come JPEG
Nome #
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 250
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 248
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 209
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 205
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 203
Liver transplantation in patients with alcoholic liver disease: A retrospective study 192
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 191
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 187
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 179
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 179
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 177
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 171
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 171
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 170
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 163
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 161
Microscopic colitis 161
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 161
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 159
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 157
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 151
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 150
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 145
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 144
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 143
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 142
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 141
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 140
Model for end-stage liver disease dynamic stratification of survival benefit 138
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 137
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 133
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 131
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 130
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 130
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 129
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 128
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 127
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 123
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 122
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 121
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 120
Regorafenib: a promising treatment for hepatocellular carcinoma 119
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 112
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 109
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 107
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 103
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 102
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 96
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 90
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 87
The new era of hepatitis C treatment: still the tip of the iceberg? 85
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 77
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 76
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 75
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 61
Totale 8.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022561 0 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025964 16 34 84 23 111 28 25 48 149 99 196 151
2025/20262.688 397 51 178 275 601 142 458 109 154 165 70 88
2026/2027108 86 22 0 0 0 0 0 0 0 0 0 0
Totale 8.270